89 related articles for article (PubMed ID: 16645147)
1. Smad3 mediates angiotensin II- and TGF-beta1-induced vascular fibrosis: Smad3 thickens the plot.
Sorescu D
Circ Res; 2006 Apr; 98(8):988-9. PubMed ID: 16645147
[No Abstract] [Full Text] [Related]
2. TGF-beta, Smad3 and the process of progressive fibrosis.
Gauldie J; Bonniaud P; Sime P; Ask K; Kolb M
Biochem Soc Trans; 2007 Aug; 35(Pt 4):661-4. PubMed ID: 17635115
[TBL] [Abstract][Full Text] [Related]
3. Autocrine TGF-beta1 mediates angiotensin II-induced proliferative response of cerebral vessels in vivo.
Yurovsky VV; Gerzanich V; Ivanova S; Dong Y; Tsymbalyuk O; Simard JM
Am J Hypertens; 2007 Sep; 20(9):950-6. PubMed ID: 17765135
[TBL] [Abstract][Full Text] [Related]
4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
5. [The role of transforming growth factor-beta1/Smad3 signaling in bronchiolitis obliterans following lung transplantation].
Liu HX; Li Y; Zhao CH; Liu Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2069-73. PubMed ID: 17925182
[TBL] [Abstract][Full Text] [Related]
6. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
Latella G; Vetuschi A; Sferra R; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Flanders KC; Gaudio E
Eur J Clin Invest; 2009 Feb; 39(2):145-56. PubMed ID: 19200168
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
8. Smad3-null mice lack interstitial cells of Cajal in the colonic wall.
Vetuschi A; Sferra R; Latella G; D'Angelo A; Catitti V; Zanninelli G; Continenza MA; Gaudio E
Eur J Clin Invest; 2006 Jan; 36(1):41-8. PubMed ID: 16403009
[TBL] [Abstract][Full Text] [Related]
9. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis is associated with transforming growth factor beta and Smad without evidence of renin-angiotensin system involvement.
Kelly B; Petitt M; Sanchez R
J Am Acad Dermatol; 2008 Jun; 58(6):1025-30. PubMed ID: 18485985
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
[TBL] [Abstract][Full Text] [Related]
12. [The mechanism of transforming growth factor beta1 in myofibroblast differentiation].
Liu HX; Wang SW; Zhao CH; Liu Y; Li Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):986-9. PubMed ID: 17961388
[TBL] [Abstract][Full Text] [Related]
13. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling.
Huang XR; Chung AC; Yang F; Yue W; Deng C; Lau CP; Tse HF; Lan HY
Hypertension; 2010 May; 55(5):1165-71. PubMed ID: 20231525
[TBL] [Abstract][Full Text] [Related]
14. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
15. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
[TBL] [Abstract][Full Text] [Related]
16. A continuous observation of the degenerative process in the intervertebral disc of Smad3 gene knock-out mice.
Li CG; Liang QQ; Zhou Q; Menga E; Cui XJ; Shu B; Zhou CJ; Shi Q; Wang YJ
Spine (Phila Pa 1976); 2009 Jun; 34(13):1363-9. PubMed ID: 19478656
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene.
Li H; Liu JP
Ann N Y Acad Sci; 2007 Oct; 1114():56-68. PubMed ID: 17934056
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF
Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta signaling in vascular fibrosis.
Ruiz-Ortega M; RodrÃguez-Vita J; Sanchez-Lopez E; Carvajal G; Egido J
Cardiovasc Res; 2007 May; 74(2):196-206. PubMed ID: 17376414
[TBL] [Abstract][Full Text] [Related]
20. Smad3 mediates immediate early induction of Id1 by TGF-beta.
Liang YY; Brunicardi FC; Lin X
Cell Res; 2009 Jan; 19(1):140-8. PubMed ID: 19079362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
